Alzheimer’s disease is the world’s most common neurodegenerative disease, affecting more than 50 million people globally.
Diabetes tech firms focusing on Type 2 patients
Diabetes technology companies remain focused on Type 2 diabetes as a source of growth. Despite the questions from investors on GLP-1 drugs that have peppered